ORCL

Oracle Corporation

65
Fundamentals60/ 100
Valuation78/ 100
Upside potential73/ 100
Risk potential19/ 100

ORCL offers stronger valuation, but that advantage does not outweigh its weaker overall profile.

TSM

Taiwan Semiconductor Manufacturing Company Limited

76
Fundamentals92/ 100
Valuation50/ 100
Upside potential59/ 100
Risk potential18/ 100

TSM has the edge over ORCL overall, supported by stronger fundamentals and lower modeled downside.

ORCL Fundamentals

MetricStatus
Healthy
Strong
Weak
Strong

ORCL's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.

TSM Fundamentals

MetricStatus
Unavailable
Unavailable
Unavailable
Strong

TSM's balance sheet is currently strong. There isn't enough data to rate its revenue, profitability and cash flow.

ORCL PE Valuation

CHEAPFAIREXPENSIVE19x37x56x74x
CHEAPFAIREXPENSIVE19x37x56x74x
LevelPEPriceVs current
Forward15x$127—
Cheap19x$119-6.8%
Current20x$127—
Fair30x$189+49%
Expensive39x$247+94%

Historical ranges are pointers, not guarantees.

ORCL's PE is in its cheap range at 20x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.

TSM PE Valuation

TSM has no meaningful PE right now: it lost money over the past year.

ORCL Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly weakening
Moderate
High

Analysts expect strong earnings and revenue growth for ORCL, but weaker profitability.

TSM Forward outlook

MetricOutlook
--
Strong growth
Strong growth
Improving
Limited
Moderate

TSM has the edge over ORCL on the outlook, with more favorable profitability expectations.

ORCL Risk to reward

ScenarioChangePrice
Upside+52%$192.98
Downside-19%$102.46

Calculated from the latest close: $127.11 on Nov 12.

ORCL has a better modeled risk to reward balance than TSM, with more potential upside relative to its potential downside.

TSM Risk to reward

ScenarioChangePrice
Upside+25%$508.50
Downside-18%$334.36

Calculated from the latest close: $405.49 on Nov 12.

TSM trails ORCL on modeled risk to reward, with less potential upside relative to its potential downside.

ORCL Earnings Per Share

Q4 2023: $3.63Q1 2024: $3.80Q2 2024: $3.71Q3 2024: $3.88Q4 2024: $4.09Q1 2025: $4.26Q2 2025: $4.34Q3 2025: $4.32Q4 2025: $5.32Q1 2026: $5.57Q2 2026: $5.83Q3 2026: $6.38Forward: $8.53
Q4 2023: $3.63Q1 2024: $3.80Q2 2024: $3.71Q3 2024: $3.88Q4 2024: $4.09Q1 2025: $4.26Q2 2025: $4.34Q3 2025: $4.32Q4 2025: $5.32Q1 2026: $5.57Q2 2026: $5.83Q3 2026: $6.38Forward: $8.53
QuarterTTM EPSYoY
Forward$8.53+34%
Q3 2026$6.38+48%
Q2 2026$5.83+34%
Q1 2026$5.57+31%
Q4 2025$5.32+30%
Q3 2025$4.32+11%
Q2 2025$4.34+17%
Q1 2025$4.26+12%
Q4 2024$4.09+13%

ORCL's earnings per share have climbed steadily: $6.38 over the past year, up 48% from the year before, and higher year over year for 15 quarters in a row.

TSM Earnings Per Share

TSM and ORCL do not have enough comparable growth data to identify a winner.

ORCL Quarterly Revenue

Q4 2023: $12.9BQ1 2024: $13.3BQ2 2024: $14.3BQ3 2024: $13.3BQ4 2024: $14.1BQ1 2025: $14.1BQ2 2025: $15.9BQ3 2025: $14.9BQ4 2025: $16.1BQ1 2026: $17.2BQ2 2026: $19.2BQ3 2026: $19.3B
Q4 2023: $12.9BQ1 2024: $13.3BQ2 2024: $14.3BQ3 2024: $13.3BQ4 2024: $14.1BQ1 2025: $14.1BQ2 2025: $15.9BQ3 2025: $14.9BQ4 2025: $16.1BQ1 2026: $17.2BQ2 2026: $19.2BQ3 2026: $19.3B
QuarterRevenueYoY
Q3 2026$19.3B+30%
Q2 2026$19.2B+21%
Q1 2026$17.2B+22%
Q4 2025$16.1B+14%
Q3 2025$14.9B+12%
Q2 2025$15.9B+11%
Q1 2025$14.1B+6.4%
Q4 2024$14.1B+8.6%

ORCL's revenue has grown year over year for 13 quarters in a row: $19.3B last quarter, up 30% from the same quarter a year ago.

TSM Quarterly Revenue

Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

TSM and ORCL do not have enough comparable growth data to identify a winner.

ORCL Free Cash Flow

Q4 2023: −$937MQ1 2024: $3.8BQ2 2024: $3.3BQ3 2024: $5.1BQ4 2024: −$2.7BQ1 2025: $71MQ2 2025: −$2.9BQ3 2025: −$362MQ4 2025: −$10BQ1 2026: −$11.5BQ2 2026: −$1.9BQ3 2026: −$5.4B
Q4 2023: −$937MQ1 2024: $3.8BQ2 2024: $3.3BQ3 2024: $5.1BQ4 2024: −$2.7BQ1 2025: $71MQ2 2025: −$2.9BQ3 2025: −$362MQ4 2025: −$10BQ1 2026: −$11.5BQ2 2026: −$1.9BQ3 2026: −$5.4B
QuarterFree cash flowYoY
Q3 2026-$5.4B-$5B
Q2 2026-$1.9B+$1.1B
Q1 2026-$11.5B-16275%
Q4 2025-$10B-$7.3B
Q3 2025-$362M-107%
Q2 2025-$2.9B-189%
Q1 2025$71M-98%
Q4 2024-$2.7B-$1.7B

ORCL has burned cash in seven of the last eight quarters: −$28.7B over the past year, against −$5.9B the year before.

TSM Free Cash Flow

Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

TSM and ORCL do not have enough comparable growth data to identify a winner.

ORCL Total Shares

Q4 2023: 2.8BQ1 2024: 2.8BQ2 2024: 2.8BQ3 2024: 2.9BQ4 2024: 2.9BQ1 2025: 2.9BQ2 2025: 2.9BQ3 2025: 2.9BQ4 2025: 2.9BQ1 2026: 2.9BQ2 2026: 2.9BQ3 2026: 3B
Q4 2023: 2.8BQ1 2024: 2.8BQ2 2024: 2.8BQ3 2024: 2.9BQ4 2024: 2.9BQ1 2025: 2.9BQ2 2025: 2.9BQ3 2025: 2.9BQ4 2025: 2.9BQ1 2026: 2.9BQ2 2026: 2.9BQ3 2026: 3B
PeriodChange %Net change
Quarterly+3%+86M shares
1 year+3.1%+91M shares
3 years+6.3%+177M shares
5 years+4.9%+139M shares
Available history-9.9%-331M shares

ORCL has 3B diluted shares, up 3.1% from a year ago.

TSM Total Shares

Q4 2023: 5.2BQ1 2024: 5.2BQ2 2024: 5.2BQ3 2024: 5.2BQ4 2024: 5.2BQ1 2025: 5.2BQ2 2025: 5.2BQ3 2025: 5.2BQ4 2025: 5.2BQ1 2026: 5.2BQ2 2026: 5.2BQ3 2026: 5.2B
Q4 2023: 5.2BQ1 2024: 5.2BQ2 2024: 5.2BQ3 2024: 5.2BQ4 2024: 5.2BQ1 2025: 5.2BQ2 2025: 5.2BQ3 2025: 5.2BQ4 2025: 5.2BQ1 2026: 5.2BQ2 2026: 5.2BQ3 2026: 5.2B
PeriodChange %Net change
Quarterly0%+45.8K shares
1 year0%+391K shares
3 years0%+528K shares
5 years0%+324K shares
Available history0%+324K shares

TSM has the edge over ORCL on shareholder dilution, with a more favorable share count trend.

ORCL Net Leverage

Q4 2023: -0.1xQ1 2024: -0.2xQ2 2024: 4.1xQ3 2024: -0.1xQ4 2024: 0.2xQ1 2025: 0.2xQ2 2025: 3.7xQ3 2025: -0.1xQ4 2025: 0.3xQ1 2026: 0.5xQ2 2026: 3.5xQ3 2026: -0.9x
Q4 2023: -0.1xQ1 2024: -0.2xQ2 2024: 4.1xQ3 2024: -0.1xQ4 2024: 0.2xQ1 2025: 0.2xQ2 2025: 3.7xQ3 2025: -0.1xQ4 2025: 0.3xQ1 2026: 0.5xQ2 2026: 3.5xQ3 2026: -0.9x
QuarterNet LeverageStatus
Q3 2026-0.9xNet Cash
Q2 20263.5xElevated
Q1 20260.5xVery low
Q4 20250.3xVery low
Q3 2025-0.1xNet Cash
Q2 20253.7xElevated
Q1 20250.2xVery low
Q4 20240.2xVery low

ORCL has the edge over TSM on leverage, with a lower net debt burden relative to earnings.

TSM Net Leverage

Q4 2023: -0.3xQ1 2024: -0.4xQ2 2024: -0.5xQ3 2024: -0.5xQ4 2024: -0.5xQ1 2025: -0.6xQ2 2025: -0.6xQ3 2025: -0.6xQ4 2025: -0.6xQ1 2026: -0.7xQ2 2026: -0.6xQ3 2026: -0.7x
Q4 2023: -0.3xQ1 2024: -0.4xQ2 2024: -0.5xQ3 2024: -0.5xQ4 2024: -0.5xQ1 2025: -0.6xQ2 2025: -0.6xQ3 2025: -0.6xQ4 2025: -0.6xQ1 2026: -0.7xQ2 2026: -0.6xQ3 2026: -0.7x
QuarterNet LeverageStatus
Q3 2026-0.7xNet Cash
Q2 2026-0.6xNet Cash
Q1 2026-0.7xNet Cash
Q4 2025-0.6xNet Cash
Q3 2025-0.6xNet Cash
Q2 2025-0.6xNet Cash
Q1 2025-0.6xNet Cash
Q4 2024-0.5xNet Cash

TSM has more cash than debt.

ORCL Weekly Momentum

MetricValueStatus
RSI41.9Neutral
Stochastic23.0Neutral

ORCL's weekly RSI is 42 (neutral) and its Stochastic is 23 (neutral).

TSM Weekly Momentum

MetricValueStatus
RSI48.8Neutral
Stochastic28.9Neutral

TSM's weekly RSI is 49 (neutral) and its Stochastic is 29 (neutral).

ORCL PE vs Technology Sector

MetricORCLSector medianRelative
PE20x28x28% below
PE %28357 pts below

ORCL has the edge over TSM on valuation relative to its sector.

TSM PE vs Technology Sector

MetricTSMSector medianRelative
PE27x28x3.3% below
PE %453510 pts above

TSM has no meaningful PE right now: it lost money over the past year.

ORCL Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$131.13.1% below
20 week MA$137.67.7% below
50 week MA$160.321% below
100 week MA$181.430% below
200 week MA$151.916% below

ORCL is in a downtrend: it's below all five of its weekly moving averages, and 16% below its 200-week average.

TSM Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$424.44.4% below
20 week MA$422.44% below
50 week MA$386.54.9% above
100 week MA$304.533% above
200 week MA$215.688% above

TSM has the edge over ORCL on trend strength, trading above more of its moving averages.

ORCL Yearly ROI

YearStart priceEnd priceROI
2020$53.5$65.0+22%
2021$65.0$89.7+38%
2022$89.7$80.9-9.9%
2023$80.9$105.4+30%
2024$105.4$169.0+60%
2025$169.0$198.0+17%
2026 YTD$198.0$127.1-36%

ORCL is down 36% so far in 2026, after finishing higher in five of the previous six years.

TSM Yearly ROI

YearStart priceEnd priceROI
2020$58.5$106.0+81%
2021$106.0$120.7+14%
2022$120.7$74.9-38%
2023$74.9$104.0+39%
2024$104.0$201.6+94%
2025$201.6$302.8+50%
2026 YTD$302.8$405.5+34%

TSM has the edge over ORCL on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key